➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKesson
McKinsey
Merck
AstraZeneca
Baxter
Medtronic

Last Updated: April 18, 2021

DrugPatentWatch Database Preview

PROCHLORPERAZINE Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which patents cover Prochlorperazine, and what generic alternatives are available?

Prochlorperazine is a drug marketed by Alpharma Us Pharms, Baxter Hlthcare, Able, Cosette, Watson Labs, Morton Grove, Athenex Inc, Emcure Pharms Ltd, Hospira, Marsam Pharms Llc, Mylan Labs Ltd, Nexus Pharms, Smith And Nephew, Teva Parenteral, West-ward Pharms Int, Wyeth Ayerst, Duramed Pharms Barr, Ivax Sub Teva Pharms, Mylan, Sandoz, and Teva Pharms. and is included in thirty-two NDAs.

The generic ingredient in PROCHLORPERAZINE is prochlorperazine maleate. There are twenty-one drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the prochlorperazine maleate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Prochlorperazine

A generic version of PROCHLORPERAZINE was approved as prochlorperazine maleate by MYLAN on October 28th, 1996.

  Start Trial

Drug patent expirations by year for PROCHLORPERAZINE
Drug Prices for PROCHLORPERAZINE

See drug prices for PROCHLORPERAZINE

Drug Sales Revenue Trends for PROCHLORPERAZINE

See drug sales revenues for PROCHLORPERAZINE

Recent Clinical Trials for PROCHLORPERAZINE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
National Institute on Drug Abuse (NIDA)Phase 2
New York State Psychiatric InstitutePhase 2
Nova Southeastern UniversityPhase 4

See all PROCHLORPERAZINE clinical trials

Pharmacology for PROCHLORPERAZINE
Drug ClassPhenothiazine
Medical Subject Heading (MeSH) Categories for PROCHLORPERAZINE

US Patents and Regulatory Information for PROCHLORPERAZINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ivax Sub Teva Pharms PROCHLORPERAZINE MALEATE prochlorperazine maleate TABLET;ORAL 040162-001 Jan 20, 1998 DISCN No No   Start Trial   Start Trial   Start Trial
Duramed Pharms Barr PROCHLORPERAZINE MALEATE prochlorperazine maleate TABLET;ORAL 089484-001 Jan 20, 1987 DISCN No No   Start Trial   Start Trial   Start Trial
Ivax Sub Teva Pharms PROCHLORPERAZINE MALEATE prochlorperazine maleate TABLET;ORAL 040162-002 Jan 20, 1998 DISCN No No   Start Trial   Start Trial   Start Trial
Duramed Pharms Barr PROCHLORPERAZINE MALEATE prochlorperazine maleate TABLET;ORAL 040207-002 May 1, 1997 DISCN No No   Start Trial   Start Trial   Start Trial
Alpharma Us Pharms PROCHLORPERAZINE prochlorperazine edisylate CONCENTRATE;ORAL 087153-001 Jun 8, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Teva Parenteral PROCHLORPERAZINE EDISYLATE prochlorperazine edisylate INJECTABLE;INJECTION 040505-001 May 30, 2003 DISCN No No   Start Trial   Start Trial   Start Trial
Wyeth Ayerst PROCHLORPERAZINE EDISYLATE prochlorperazine edisylate INJECTABLE;INJECTION 086348-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Medtronic
Dow
Moodys
Johnson and Johnson
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.